Loading company…
Inomagen Therapeutics, Inc
PrivateWon 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Department of Health and Human ServicesNational Institutes of Health
- SAM UEI
- G361MCGUDEE5
- Founded
- —Source: [GOV]
- Headquarters
- CHICAGO, IllinoisSource: [GOV]
- Country
- United StatesSource: [GOV]
- Headcount
- 4Source: [GOV]
$0Source: [GOV]Total raised
UndisclosedSource: [GOV]Last valuation
Overview
Inomagen Therapeutics, Inc has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $3,849,106 between 2021 and 2022. These are non-dilutive federal research grants, not equity financing. The company is based in CHICAGO, Illinois.
Funding rounds
2 rounds2 rounds · latest SBIR Phase II award (HHS), Jan 2022
Sign in to see 2 rounds.
Sign inInvestors
No investors recorded yet for Inomagen Therapeutics, Inc.
Add an investorPeople
LeadershipAcquisitions
Inomagen Therapeutics, Inc has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for Inomagen Therapeutics, Inc.
Add diversity data